To evaluate the protective effects of Plantago Major extract (PME) in stimulated BV-2 microglial cells and its anti-oxidant properties, cell viability assessment was performed by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. Lipopolysaccharide (LPS) was used to activate BV-2 microglia. Nitric oxide (NO) levels were measured using Griess assay. Tumor necrosis factor-alpha (TNF-α) production was evaluated by enzyme-linked immunosorbent assay (ELISA). Antioxidant properties were evaluated by 1, 1-diphenyl-2-picryl-hydrazyl (DPPH) radical scavenging assay. LPS-activated excessive release of NO in BV-2 cells was significantly inhibited by PME (P < 0.001 at 100 μg/mL). PME also scavenged DPPH radicals in a dose-dependent manner (P < 0.05 at 10 μg/mL and P < 0.001 at 20~200 μg/mL). These results indicate that PME attenuated neuroinflammatory responses in LPS-activated BV-2 microglia by inhibiting excessive production of pro-inflammatory mediators such as NO and TNF-α. The anti-neuroinflammatory potential of PME may be related to its strong antioxidant properties.
critical role in the neuroinflammatory processes by releasing toxic mediators including nitric oxide (NO), inducible NO synthase (iNOS), interleukins (IL), tumor necrosis factoralpha (TNF-α), and free radicals (Matsumoto et al., 1992; Gao et al., 2002) . Activated microglia and the released inflammatory mediators may lead to several neurodegenerative diseases including multiple sclerosis (MS), Parkinson's disease (PD), Alzheimer's disease (AD) and Huntington's disease (Chiang et al., 2003) . It is well known that microglia can be activated by lipopolysaccharide (LPS) and is recognized to be a useful in vitro tool for studying neuroinflammatory mechanisms (Kim et al., 2004) . LPS activated BV-2 microglia cells enhance the production of immune-related cytotoxic factors and pro-inflammatory cytokines (Kim et al., 2004; Park et al., 2013) . Thus, the control of microglial activation has been suggested as a promising therapeutic target in combating neuroinflammatory-mediated neurodegenerative diseases. Plantago L. (Plantaginaceae) is a genus widely distributed all over the world, and more than about 300 species have been reported (Beara et al., 2009 ○ CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. To obtain the Plantago Major leaf extract (PME), fresh leaves were washed to remove debris and air-dried for two days. The dried leaves were then ground to powder using an electric blender (Model 4250, Braun Germany). The powdered leaf was extracted with three volumes of 80% ethanol with mixing at room temperature for 1 h. The extract was filtered and lyophilized to obtain ethanol extract concentrate.
The EtOH extract of PME obtained was re-suspended in water:EtOH (9:1, v/v) and partitioned in turn via n-hexane, chloroform, ethyl acetate (EA) and n-butanol solvents. Since EA fraction of PME showed potent antioxidant effect in our preliminary evaluation, further studies on anti-neuroinflammatory effects in LPS-stimulated BV-2 microglial cells was investigated using PME extract. The PME extract was dissolved in sterile distilled water, filtered on 0.22 μm filters and stored at -20℃. All reagents used in this study were the highest grade commercially available. The anti-oxidant activity of the PME extract was determined using the stable radical 2, 2-diphenyl-1-picrylhydrazyl (DPPH, Sigma-Aldrich, St. Louis, MO, USA). The radical scavenging capacity was evaluated by employing a reaction mixture constituted by aliquots of the PME extract and a DPPH methanolic solution as described previously (Nanjo et al., 1996) . BV-2 microglia cells were cultured at 37℃ in 5% CO 2 in DMEM (Invitrogen, Carlsbad, CA, USA) supplemented with 5% FBS (Hyclone, Logan, UT, USA) and antibiotics (Invitrogen).
In all experiments, cells were pre-treated with PME extract at indicated concentrations 10~100 μg/mL) for 1 h before the addition of LPS (5 μg/mL, Sigma-Aldrich, St Louis, MO, USA) in serum free DMEM. An equal volume of sterile water was added to all control treatments. For viability assay, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide (MTT, Sigma-Aldrich, St. Louis, MO, USA) assay was used as described previously (Kim et al., 2011) . Production of NO was assayed by measuring the levels of nitrite in the culture supernatant using colorimetric assay with Griess reagent (Kim et al., 2011) It is well known that DPPH radical assay is one of the widely used methods for evaluating the free radical scavenging activities of several antioxidants in a relatively short -413 -period of time (Nanjo et al., 1996) . Several studies have reported that antioxidants play important roles in the prevention of aging and age-related diseases (Uttara et al., 2009 ).
As shown in Fig. 1 , PME exhibited significant DPPH radical scavenging activity in a concentration-dependent manner showing a maximum effect at 100 μg/mL (P < 0.001). Treatment with PME extract at indicated concentrations (10~100 μg/mL) did not affect the overall cell viability nor did they exhibit any cytotoxicity on BV2 microglia cells. Although not significant, PME at 200 μg/mL concentration showed moderate signs of cytotoxicity (Fig. 2) . Therefore 100 μg/mL of PME was utilized as maximum concentration for further experiments and activities. It was well documented that one Fig. 1 . Effect of PME extract on DPPH radical scavenging activity. The capacities to scavenge DPPH radicals by different concentrations (10, 20, 40, 60, 80 and 100 μg/mL) of PME extract (Plantago Major-ethylacetate) . Data are presented as mean ± SEM (n = 3) for three independent experiments; *P < 0.05, and ***P <0.001, compared with control group. Fig. 2 . Effects of PME extract on the viability of BV-2 microglial cells. Viability in PME extract-treated cells was determined using MTT assay in the presence or absence of LPS (5 μg/mL). The results are depicted as percentage of control samples. Data are presented as the mean ± S.E.M. (n = 3) for three independent experiments. No significant when difference compared with control group (PME: Plantago Major-ethylacetate). Fig. 4 . Effect of PME extract on TNF-α production in LPSstimulated BV-2 microglial cells. Suppression of pro-inflammatory cytokine TNF-α expression by PME extract was measured with ELISA test. BV-2 cells were treated with PME extract at 50 and 100 μg/mL with or without LPS (5 μg/mL) for 4 h. The TNF-α in the culture supernatant was evaluated using a murine TNF-α ELISA kit. Data are presented as the mean ± S.E.M. (n = 3) for three independent experiments. #P <0.001, when compared with control group. **P < 0.01 and ***P < 0.001, when compared with LPS alone group by Student t-test (PME: Plantago Major-ethylacetate, LPS: Lipopolysaccharide, TNF-α: Tumor necrosis factor-α). Fig. 3 . Effect of PME extract on NO Production in LPS stimulated BV-2 microglial cells. BV-2 cells were treated with PME extract at various concentrations (20, 40, 80 and 100 μg/mL) with or without LPS (5 μg/mL) for 4 h. The nitrite in the culture supernatant was evaluated using Griess reagent. Data are presented as the mean ± S.E.M. (n = 3) for three independent experiments. #P < 0.001, when compared with control group. **P < 0.01 and ***P < 0.001, when compared with LPS alone treated group by Student t-test (PME: Plantago Major-ethylacetate, LPS: Lipopolysaccharide).
-414 -of the major pro-inflammatory mediators released by activated microglia is NO, an uncharged lipophilic molecule that is toxic to neurons. Elevated levels of pro-inflammatory cytokines and mediators are also up-regulated in brain once microglial cells are activated (Gao et al., 2002; Merill et al., 2009 ). Cells treated with LPS (5 μg/mL) alone significantly increased in NO levels (P < 0.001). Pre-treatment with PME extract at indicated concentrations significantly and dosedependently suppressed the excessive release of NO in BV-2 cells in a (Fig. 3) . Although PME at 10 μg/mL concentration did not influence the NO release, 20, 40, 60, 80 and 100 μg/ mL concentrations showed significant effects. The maximum effect was observed at a concentration of 100 μg/mL (P < 0.001). As shown in Fig. 4 , TNF-α levels increased significantly after LPS treatment (5 μg/mL) when compared to those in untreated cells (P < 0.001). However, PME extract significantly inhibited TNF-α production in a concentrationdependent manner in LPS-stimulated BV-2 cells (P < 0.01 at 50 μg/mL and P < 0.001 at 100 μg/mL, respectively).
Therefore, inhibition of cytokine production in activatedmicroglia might serve as a key mechanism in the control of neuroinflammatory responses in neurodegeneration.
In the present study, PME extract significantly inhibited the LPS-stimulated increase in NO production and suppressed the iNOS protein expression in LPS-stimulated BV-2 cells. Activated microglial cells are known to release several proinflammatory cytokines including TNF-α which may not only amplify the inflammatory cascade, but also cause inflammatory injury (Perry et al., 2001; Frankola et al., 2011) . Therefore, we investigated whether PME extract had an effect on the production of TNF-α in LPS activated BV-2 microglial cells. This indicated that the leaves could be included in the preparation of P. major derived herbal medicines. Our results indicate that PME extract significantly suppressed the production of TNF-α in the LPSactivated BV-2 cells. This study revealed that P. major extract attenuated the neuroinflammatory processes in LPSinduced BV-2 microglial cells. The anti-neuroinflammatory effects of PME extract might be attributed it its regulatory actions on proinflammatory cytokine such as TNF-α and its strong antioxidant effects. Based on our results PME extract might be developed as a promising candidate for the treatment of neuroinflammation-mediated neurological disorders.
